Delivery Order SPE2DB22D3501-SPE2DB25FWS65
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on August 13, 2025, for Eliquis 5 mg tablets in a 60-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $10,815.81 and is set to be completed by August 14, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This competitive, firm fixed-price delivery order has a ceiling value of $66,244.88 and an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,311.84 by the Defense Logistics Agency (DLA) on April 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). The contract, which is not set-aside, utilizes firm fixed pricing and carries an ultimate completion date of May 1, 2025. Performance of this order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $4,958.52. This firm fixed-price delivery order, issued under a non-competitive set-aside designation, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date for...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,180.32 by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for ELIQUIS 5 mg tablets (60 count) with a ceiling value of $28,889.03 and a firm fixed price structure. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract contains no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $27,225.53 on August 27, 2025, for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,156.88 by the Defense Logistics Agency Medical Supply Chain on July 25, 2025, for the supply of Eliquis 5 mg tablets (60-count). The contract represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and is a child contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWS65Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order contract on August 4, 2025, by the Defense Logistics Agency for the supply of ELIQUIS 5 mg tablets (60-count units) under a firm fixed price arrangement with a ceiling value of $28,274.15. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 5, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's $999.99 billion prime IDC with DLA Troop Support Medical enables supply of an extensive portfolio of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers globally. This specific delivery order for ELIQUIS, an anticoagulant medication, reflects the company's ongoing role in fulfilling pharmaceutical supply requirements within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 8/4/25 |